Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View


Barclays Upgrades Agios Pharmaceuticals to Overweight, Announces $46 Price Target


Benzinga | Oct 22, 2020 06:41AM EDT

Barclays Upgrades Agios Pharmaceuticals to Overweight, Announces $46 Price Target

Barclays analyst Peter Lawson upgrades Agios Pharmaceuticals (NASDAQ:AGIO) from Equal-Weight to Overweight and announces $46 price target.






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC